ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,522.40
1.05%
다우존스 지수
40,589.34
1.64%
Bitcoin
67,868.42
-0.07%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. Merck and Co Inc (MRK)

  7. Merck and Co Inc (MRK) 뉴스

MRK Merck and Co Inc

125.26
-0.59 (-0.47%)
27 7월(7) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Merck and Co Inc MRK NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.59 -0.47% 125.26 09:00:00
개장가 저가 고가 종가 전일 종가
126.84 125.05 128.73 125.26 125.85
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/07/202419:50BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
24/07/202401:52BWMerck Announces Fourth-Quarter 2024 Dividend
23/07/202419:45BWMerck Announces Topline Results from Phase 2b/3 Trial of..
16/07/202419:45BWMerck to Share New Research and Host Community-Focused..
12/07/202419:45BWMerck Completes Acquisition of EyeBio
09/07/202421:30BWMerck Animal Health Completes Acquisition of Elanco’s Aqua..
09/07/202421:28PRNUSElanco Completes Sale of Aqua Business
01/07/202421:15BWMerck and Orion Announce Mutual Exercise of Option Providing..
01/07/202419:45BWMerck to Hold Second-Quarter 2024 Sales and Earnings..
28/06/202419:53BWMerck Receives Positive EU CHMP Opinion for WINREVAIR™..
28/06/202409:18BWCDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™..
27/06/202420:13IHMARKETNEWSInteractive Brokers Loses $48 Million on NYSE, Amazon..
27/06/202408:45BWPatritumab Deruxtecan BLA Submission Receives Complete..
26/06/202405:05BWUSDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu..
18/06/202420:02IHMARKETNEWSFisker Files for Bankruptcy, Chegg Stocks Rise on 23%..
18/06/202406:29BWU.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent..
18/06/202406:15BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus..
05/06/202419:45BWMerck to Participate in the Goldman Sachs 45th Annual Global..
05/06/202404:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202404:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202403:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202403:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202403:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202403:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202403:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/06/202422:10IHMARKETNEWSEconomic Worries May Lead To Weakness On Wall Street
31/05/202405:39EDGAR2Form CERT - Certification by an exchange approving..
31/05/202405:28EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
31/05/202405:14EDGAR2Form 8-K - Current report
29/05/202422:10IHMARKETNEWSRising Treasury Yields May Weigh On Wall Street
29/05/202420:34IHMARKETNEWSRobinhood Shares Surge 3.3% on Stock Buyback Announcement;..
29/05/202420:15BWFDA Grants Priority Review to Merck’s Application for..
29/05/202419:45BWMerck to Acquire EyeBio
29/05/202405:44IHMARKETNEWSNasdaq Climbs To Another Record Closing High But Dow Sees..
29/05/202405:31EDGAR2Form SD - Specialized disclosure report
29/05/202404:12BWMerck Announces Third-Quarter 2024 Dividend
28/05/202419:45BWMerck Announces Phase 3 KEYNOTE-522 Trial Met its Overall..
20/05/202419:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/05/202405:15EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
16/05/202400:31EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
15/05/202419:45BWMerck to Present New Data at 2024 ASCO Annual Meeting..
13/05/202419:45BWMerck Provides Update on Phase 3 KeyVibe-010 Trial..
09/05/202420:05PRNCASanté Canada approuve KEYTRUDA® pour le traitement, en..
09/05/202419:45BWMerck Provides Update on Phase 3 KEYNOTE-B21 Trial..
08/05/202419:45BWMerck to Participate in the Bank of America Securities 2024..
07/05/202405:29EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NYSE
MRK
Merck
BIT
P17XN2
BNP Paribas Issuance
COIN
SCCOUSD
SiaCashCoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유